1-2 of 2
Ilona Seferyńska
Close
Sort by
Journal Articles

Long-Term Remission Maintenance on Weekly Imatinib Dosage In Patients with FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukaemia

Grzegorz Helbig, Marek Hus, Andrzej Moskwa, Krystyna Zawilska, MD, PhD, Lucyna Molendowicz-Portala, Alina Świderska, Alina Urbanowicz, Ewa ˙Zuk, Małgorzata Raźny, Marek Rodzaj, Ilona Seferyńska, Małgorzata Całbecka, Ryszard Wichary, Slawomira Kyrcz-Krzemien, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4097.
https://doi.org/10.1182/blood.V116.21.4097.4097
Published: 2010
Journal Articles

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Clinical Trials & Observations Brief Report
Tadeusz Robak, Krzysztof Jamroziak, Joanna Gora-Tybor, Jerzy Z. Blonski, Marek Kasznicki, Jadwiga Dwilewicz-Trojaczek, Elzbieta Wiater, Andrzej Zdunczyk, Jacek Dybowicz, Anna Dmoszynska, Maria Wojtaszko, Barbara Zdziarska, Malgorzata Calbecka, Aleksandra Kostyra, Andrzej Hellmann, Krzysztof Lewandowski, Beata Stella-Holowiecka, Kazimierz Sulek, Krzysztof Gawronski, Aleksander B. Skotnicki, Wieslaw Nowak, Krystyna Zawilska, Lucyna Molendowicz-Portala, Janusz Kloczko, Jarosław Sokolowski, Krzysztof Warzocha, Ilona Seferyńska, Bernardeta Ceglarek, Lech Konopka, for the Polish Adult Leukemia Group
Journal: Blood
Blood (2007) 109 (9): 3672–3675.
https://doi.org/10.1182/blood-2006-08-042929
Published: 2007